Lamia Ait-Ali

Dr. Lamia Ait-Ali


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2017 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
IVIsrael Valverde
Israel Valverde
GGGorka Gomez-Ciriza
Gorka Gomez-Ciriza
THTarique Hussain
Tarique Hussain
CSCristina Suarez-Mejias
Cristina Suarez-Mejias
MVMaria N Velasco-Forte
Maria N Velasco-Forte
AHAmir-Reza Hosseinpour
Amir-Reza Hosseinpour
To evaluate the impact of 3D printed models (3D models) on surgical planning in complex congenital heart disease (CHD). A prospective case-crossover study involving 10 international centres and 40 patients with complex CHD (median age 3 years, range 1 month–34 years) was conducted. Magnetic resonance imaging and computed tomography were used to acquire and segment the 3D cardiovascular anatomy. Models were fabricated by fused deposition modelling of polyurethane filament, and dimensions were compared with medical images. Decisions after the evaluation of routine clinical images were compared with those after inspection of the 3D model and intraoperative findings. Subjective satisfaction questionnaire was provided. 3D models accurately replicate anatomy with a mean bias of −0.27 ± 0.73 mm. Ninety-six percent of the surgeons agree or strongly agree that 3D models provided better understanding of CHD morphology and improved surgical planning. 3D models changed the surgical decision in 19 of the 40 cases. Consideration of a 3D model refined the planned biventricular repair, achieving an improved surgical correction in 8 cases. In 4 cases initially considered for conservative management or univentricular palliation, inspection of the 3D model enabled successful biventricular repair. 3D models are accurate replicas of the cardiovascular anatomy and improve the understanding of complex CHD. 3D models did not change the surgical decision in most of the cases (21 of 40 cases, 52.5% cases). However, in 19 of the 40 selected complex cases, 3D model helped redefining the surgical approach.

16 August 2009 in Heart
Verified
Journal Article
Open access
PDF file
LALamia Ait-Ali
Lamia Ait-Ali
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
IFIlenia Foffa
Ilenia Foffa
ISIsabella Spadoni
Isabella Spadoni
EVEliseo Vano
Eliseo Vano
EPEugenio Picano
Eugenio Picano
Background: The seventh Committee on “Biological Effects of Ionizing Radiation” (BEIR VII, 2006) underlines “the need of studies of infants who are exposed to diagnostic radiation because catheters have been placed in their hearts”. Objective: To determine the lifetime attributable risk (LAR) of cancer associated with the estimated cumulative radiological dose in 59 children (42 male, age 2.8±3.2 years) with complex congenital heart disease, and to assess chromosomal DNA damage after cardiac catheterisation procedures. Methods: In all patients, the cumulative exposure was estimated as effective dose in milliSievert (mSv), and LAR cancer was determined from the BEIR VII report. In a subset of 18 patients (13 male, age 5.2±5.7 years) micronucleus as a biomarker of DNA damage and long-term risk predictor of cancer was assayed before and 2 h after catheterisation procedures. Dose–area product (Gy cm2) was assessed as a measure of patient dose. Results: The median life time cumulative effective dose was 7.7 mSv per patient (range 4.6–41.2). Cardiac catheterisation procedures and CT were responsible for 95% of the total effective dose. For a 1-year-old child, the LAR cancer was 1 in 382 (25th to 75th centiles: 1 in 531 to 1 in 187) and 1 in 156 (25th to 75th centiles: 1 in 239 to 1 in 83) for male and female patients, respectively. Median micronucleus values increased significantly after the procedure in comparison with baseline (before 6‰ vs after 9‰, p=0.02). The median dose–area product value was 20 Gy cm2 (range 1–277). Conclusion: Children with congenital heart disease are exposed to a significant cumulative dose. Indirect cancer risk estimations and direct DNA data both emphasise the need for strict radiation dose optimisation in children.

11 April 2006 in European Heart Journal
Verified
Journal Article
Open access
PDF file
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
LALamia Ait-Ali
Lamia Ait-Ali
NBNicoletta Botto
Nicoletta Botto
SMSamantha Manfredi
Samantha Manfredi
GMGaetano Mottola
Gaetano Mottola
EPEugenio Picano
Eugenio Picano
Aims Medical radiological exposure is associated with an additional risk of cancer. Children with repaired congenital heart disease (CHD) are theoretically at a relatively greater cancer risk as the radiological exposure can be intensive in these patients. Chromosomal aberrations test (CA) and micronucleus assay (MN) in peripheral blood lymphocytes are biomarkers of chromosomal damage and intermediate endpoints in carcinogenesis.

11 April 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
IFIlenia Foffa
Ilenia Foffa
LALamia Ait-Ali
Lamia Ait-Ali
PPPaola Panesi
Paola Panesi
MMMassimiliano Mariani
Massimiliano Mariani
PFPierluigi Festa
Pierluigi Festa
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
Background: The purpose of our study was to investigate the potential contribution of germline mutations in NOTCH1, GATA5 and TGFBR1 and TGFBR2 genes in a cohort of Italian patients with familial Bicuspid Aortic Valve (BAV). Methods: All the coding exons including adjacent intronic as well as 5′ and 3′ untranslated (UTR) sequences of NOTCH1, GATA5, TGFBR1 and TGFBR2 genes were screened by direct gene sequencing in 11 index patients (8 males; age = 42 ± 19 years) with familial BAV defined as two or more affected members. Results: Two novel mutations, a missense and a nonsense mutation (Exon 5, p.P284L; Exon 26, p.Y1619X), were found in the NOTCH1 gene in two unrelated families. The mutations segregated with the disease in these families, and they were not found on 200 unrelated chromosomes from ethnically matched controls. No pathogenetic mutation was identified in GATA5, TGFBR1 and TGFBR2 genes. Conclusions: Two novel NOTCH1 mutations were identified in two Italian families with BAV, highlighting the role of a NOTCH1 signaling pathway in BAV and its aortic complications. These findings are of relevance for genetic counseling and clinical care of families presenting with BAV. Future studies are needed in order to unravel the still largely unknown genetics of BAV.

1 July 2007 in Stroke
Verified
Journal Article
Closed access
PDF file
NBNicoletta Botto
Nicoletta Botto
ISIsabella Spadoni
Isabella Spadoni
SGSandra Giusti
Sandra Giusti
LALamia Ait-Ali
Lamia Ait-Ali
RSRosa Sicari
Rosa Sicari
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
Background and Purpose— Patent foramen ovale (PFO) has been identified as a potential risk factor for cerebrovascular ischemia. Procoagulant mutations may increase the risk and impact the choice of appropriate therapy for secondary prevention. We evaluated the prevalence of the 2 most common genetic risk factors for thromboembolism, factor V Leiden (G1691A) and prothrombin G20210A, in young PFO patients who were referred for percutaneous transcatheter closure of their PFO. Methods— Ninety-seven patients (50 men; mean±SD age, 40.9±10.0 years) with first-ever cerebrovascular events before the age of 55 years and 160 age-matched control subjects (69 men; mean±SD age, 40.4±10.5 years) were recruited into the study. Factor V Leiden and prothrombin G20210A mutations were detected by using a multiplex allele-specific polymerase chain reaction assay. Results— The prevalence of subjects carrying at least 1 prothrombotic genotype was significantly higher in the group of PFO patients than in the group of controls (10.3% vs 2.5%; χ 2 =7.2, P =0.008). Two patients (2.1%) versus 1 control subject (0.6%) and 8 cases (8.2%) versus 3 controls (1.9%) were carriers for factor V Leiden and prothrombin G20210A mutations, respectively. After adjustment for other vascular risk factors, the combination of either factor V Leiden or prothrombin G20210A and PFO was associated with a 4.7-fold (95% CI=1.4 to 16.1; P =0.008) increased risk of cerebral ischemia in young patients. Conclusions— Our results indicate that prothrombotic mutations are important risk factors for cerebral ischemia in young patients with PFO. Screening for thrombotic mutations should be considered in young patients with PFO-related ischemic events.

18 March 2006 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
PFPierluigi Festa
Pierluigi Festa
LALamia Ait-Ali
Lamia Ait-Ali
ACAlfredo Giuseppe Cerillo
Alfredo Giuseppe Cerillo
DMDaniele De Marchi
Daniele De Marchi
BMBruno Murzi
Bruno Murzi